Discovery of AZD3199, An Inhaled Ultralong Acting β2 Receptor Agonist with Rapid Onset of Action.
about
Investigational beta-2 adrenergic agonists for the treatment of chronic obstructive pulmonary disease.Benchmarking of Human Dose Prediction for Inhaled Medicines from Preclinical In Vivo Data.Model-based evaluation of pulmonary pharmacokinetics in asthmatic and COPD patients after oral olodaterol inhalation.Translational model to predict pulmonary pharmacokinetics and efficacy in man for inhaled bronchodilators.
P2860
Discovery of AZD3199, An Inhaled Ultralong Acting β2 Receptor Agonist with Rapid Onset of Action.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Discovery of AZD3199, An Inhal ...... st with Rapid Onset of Action.
@en
Discovery of AZD3199, An Inhal ...... st with Rapid Onset of Action.
@nl
type
label
Discovery of AZD3199, An Inhal ...... st with Rapid Onset of Action.
@en
Discovery of AZD3199, An Inhal ...... st with Rapid Onset of Action.
@nl
prefLabel
Discovery of AZD3199, An Inhal ...... st with Rapid Onset of Action.
@en
Discovery of AZD3199, An Inhal ...... st with Rapid Onset of Action.
@nl
P2093
P2860
P356
P1476
Discovery of AZD3199, An Inhal ...... ist with Rapid Onset of Action
@en
P2093
Adrian Fisher
Alan Young
Alex Mullen
Alexander Humphries
Alice Flaherty
Andrew Bailey
Anthony Cook
Anthony Ingall
David Nicholls
Elaine Cadogan
P2860
P304
P356
10.1021/ML4005232
P577
2014-02-08T00:00:00Z